[1]
E. Saffarieh, S. Nassiri, and M. Mirmohammadkhani, “Predicting value of HE4 and CA125 markers for optimal cytoreductive surgery in ovarian cancer patients”, Eur J Transl Myol, vol. 32, no. 3, Aug. 2022.